BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24864229)

  • 1. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
    Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
    Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
    Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.
    Torosyan Y; Dobi A; Glasman M; Mezhevaya K; Naga S; Huang W; Paweletz C; Leighton X; Pollard HB; Srivastava M
    Oncogene; 2010 Apr; 29(17):2457-66. PubMed ID: 20190808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.
    Mori S; Nada S; Kimura H; Tajima S; Takahashi Y; Kitamura A; Oneyama C; Okada M
    PLoS One; 2014; 9(2):e88891. PubMed ID: 24558442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1.
    Baskin R; Sayeski PP
    Cell Signal; 2012 Feb; 24(2):435-442. PubMed ID: 21963429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell survival kinase SGK1 and its targets FOXO3a and NDRG1 in aged human brain.
    Sahin P; McCaig C; Jeevahan J; Murray JT; Hainsworth AH
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):623-33. PubMed ID: 23363009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
    Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
    Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.
    Liu W; Wang X; Liu Z; Wang Y; Yin B; Yu P; Duan X; Liao Z; Chen Y; Liu C; Li X; Dai Y; Tao Z
    Br J Cancer; 2017 Oct; 117(8):1139-1153. PubMed ID: 29017179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P; Ström A; Gustafsson JÅ
    Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.
    Amato R; D'Antona L; Porciatti G; Agosti V; Menniti M; Rinaldo C; Costa N; Bellacchio E; Mattarocci S; Fuiano G; Soddu S; Paggi MG; Lang F; Perrotti N
    J Mol Med (Berl); 2009 Dec; 87(12):1221-39. PubMed ID: 19756449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells.
    Cornforth AN; Davis JS; Khanifar E; Nastiuk KL; Krolewski JJ
    Oncogene; 2008 Jul; 27(32):4422-33. PubMed ID: 18391984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y; Wang Z; Kong D; Li R; Sarkar SH; Sarkar FH
    J Biol Chem; 2008 Oct; 283(41):27707-27716. PubMed ID: 18687691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal carcinoma cells--regulation of survival and growth by SGK1.
    Lang F; Perrotti N; Stournaras C
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1571-5. PubMed ID: 20541034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.
    Rice L; Handayani R; Cui Y; Medrano T; Samedi V; Baker H; Szabo NJ; Rosser CJ; Goodison S; Shiverick KT
    J Nutr; 2007 Apr; 137(4):964-72. PubMed ID: 17374662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANXA7-GTPase as Tumor Suppressor: Mechanisms and Therapeutic Opportunities.
    Leighton X; Eidelman O; Jozwik C; Pollard HB; Srivastava M
    Methods Mol Biol; 2017; 1513():23-35. PubMed ID: 27807828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
    Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
    Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
    Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.